Invivo Corp.
Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient safety.
RELATED CONTENT
Radiologists from Synergy Radiology Associates (SRA) in Houston are using the power of 3-D medical imaging and subspecialty radiology to provide better patient care for men with suspicious prostate cancer findings.
July 17, 2017 
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroNav ...
March 23, 2017 Invivo has expanded its breast and prostate imaging solutions portfolio with the addition of the Sentinelle product line of advanced MRI coils.
October 13, 2014 
CorTechs Labs Inc. renewed and expanded its partnership and distribution agreement with Invivo Corp. for NeuroQuant, a software solution for volumetric brain atrophy in the U.S. healthcare market.
February 04, 2014 Invivo and iCAD Inc. announced the companies have entered into a global research, development and commercial agreement.
Under the agreement, iCAD will develop advanced magnetic resonance imaging (MRI) analysis software products, which Invivo will incorporate into its suite of MRI product solutions for global commercial sale.
April 01, 2013 
Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.
October 31, 2012 
Invivo’s DynaCAD with ONCAD offers a new way of interpreting magnetic resonance imaging (MRI). ONCAD is the first, fully automated morphological analysis system designed to detect suspicious breast lesions as part of a second check during review of contrast enhanced MRI.
October 31, 2012 
Invivo’s NeuroQuant makes integrating functional magnetic resonance imaging (fMRI) plus structural MRI volumetrics into everyday workflow easier so any MR center can utilize these technologies.
October 30, 2012 
At 59, George LaVie (not his real name) faced an uncertain future. Based on rising PSA levels (prostate-specific antigen), he had undergone a transrectal ultrasound biopsy (TRUS) to attempt to determine the presence of disease. The results were negative.
December 15, 2011 
Invivo’s DynaCAD for Prostate and DynaTRIM are an award-winning combination (Medical Design Excellence Gold Award, 2010). The software and hardware combination streamlines workflow and improves productivity and increases diagnostic confidence for both imaging and magnetic resonance (MR)-guided intervention.
November 02, 2011